Proton pump inhibitors negatively impact survival of PD-1 inhibitor based therapies in metastatic melanoma patients

Autor:	M. Wind-Rotolo, Zoi Tsourti, Erika Richtig, F. Tuchmann, George Coukos, G. Richtig, C. Holler, Douglas Hanahan, Urania Dafni, Panagiota Zygoura, Krisztian Homicsko, Olivier Michielin
Rok vydání:	2018
Předmět:	0301 basic medicine Metastatic melanoma biology business.industry Hematology 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Oncology 030220 oncology & carcinogenesis Programmed cell death 1 biology.protein Cancer research Medicine business
Zdroj:	Annals of Oncology. 29:x40
ISSN:	0923-7534
DOI:	10.1093/annonc/mdy511.001
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84abb7238fb7797464d8f50f766342a0 https://doi.org/10.1093/annonc/mdy511.001 Zobrazit plný text záznamu